Indices-Pac Research Corporation’s AbbVie ABBV Stock Holding History

Indices-Pac Research Corporation’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-5,063	Closed	-$260K	–	4
2014 Q1	$260K	Sell	5,063 -2,511	-33%	-$127K	0.17%	179
2013 Q4	$400K	Buy	7,574 +407	+6%	+$20K	0.25%	133
2013 Q3	$321K	Sell	7,167 -12,839	-64%	-$569K	0.21%	134
2013 Q2	$827K	Buy	+20,006	New	+$875K	0.54%	62

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Indices-Pac Research Corporation's ABBV Position: Q2 2014 in Review

Indices-Pac Research Corporation sold out of AbbVie (ABBV) in Q2 2014, closing a stake of 5,063 shares — an estimated $260K sold.

Indices-Pac Research Corporation first reported a position in ABBV in Q2 2013 and held it in 4 quarters. The position peaked at $827K in Q2 2013. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Indices-Pac Research Corporation reported no remaining AbbVie position as of Q2 2014 after selling out during the quarter.
Indices-Pac Research Corporation sold 5,063 AbbVie shares in Q2 2014, an estimated $260K.
Indices-Pac Research Corporation first reported a position in AbbVie in Q2 2013 and held it in 4 quarters.
Indices-Pac Research Corporation's AbbVie position peaked at $827K in Q2 2013.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Indices-Pac Research Corporation's 13F filing for Q2 2014.